The Alzheimer’s Drug Discovery Foundation (ADDF) has released its 2024 Digital Annual Report, highlighting a future shaped by combination therapies and precision medicine for Alzheimer’s disease. The report organizes ADDF’s work across therapeutics, diagnostics, and prevention so readers can connect specific projects to a broader pipeline and see how today’s investments set up tomorrow’s breakthroughs. Motion, infographics, and photography work together to explain what is new, why it matters, and how donors and partners can help promising ideas scale.
About the Alzheimer’s Drug Discovery Foundation
ADDF partners with a global community of researchers, clinicians, and donors to accelerate the development of drugs and diagnostics for Alzheimer’s. Its venture philanthropy model supports high-potential science that might otherwise struggle to attract funding, with an emphasis on getting effective tools into clinics and communities.
